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LETTERS TO THE EDITOR 
Amiodarone and Desethylamiodarone: 
Plasma Concentrations, Therapeutic Effects 
and Side Efkets 
Wereadwiib much in,crcs,,bcaniilc by Grccnberge,al (II and wc 
wan, 10 con,rib”,e LG The discursm” on ibe ,mpo”an, isSUe of the 
relation belween plasma comcwa,ions and ,he effear of arm&- 
mne and desethylamiodaroae. 
The problem of estabiirhing lberapeutic rmgcr fur droga i3 
di6iC”l, (2-i). Reliable ,berape”,lc range3 have been found for * few 
drugs and can be used. in ndditmn to other ciiwal wiabler. aa a 
guide to therapy. Among nntiarrbyibmic drum .miodarone )s an 
even more difficul, case because of its umque pbarmacokmet~ 
and pbarmacodynamx pmf;ic 0:. Ammdaronc snd :!s atliw melab- 
oli,e, N-derc,bylamiodamer. arc known ,D ha”s mukiplc CBE- 
lrophyriologic &c,r 65.7). Because fbe~ d~tnbutmn in body 
tissues is ex,cnsi”e, the amoun, of drug prcscn, in bloud a, \,sndy 
staterepresents onlya”eryrmallfrac,ionof:bewholc body conren, 
(81. In addition, amiodarone and N-desethylamwdarone plasma 
elimination half-lives can be 2, month and their onse, of action 1s 
very delayed. even m the presence of “Lhera~eutx” plasma con- 
centrations (9): side effects observed during amicdarorw fherapy 
also seem lo be dependent cm the duration of lrealmen, (101. Many 
investigators have looked for a rela,,on between amicdamne and 
N-dcssthylamiodamne plasma concen,ra,~~s atd ,herapeu,lc ef- 
bacy or ride eliectr (5). Previous radier including >300 pa,ienn 
with various kinds of arrhythmias do no, allow reliable conclusions. 
On the other hand, it should be emphasized [ha, the likelihwd of 
finding wme correllion is necessarily low in sfudies no, expressly 
dcriwd for fha, ,WPOSC?. As Mason 6, staled m hs recent 
canprebe”si”e review 0” amiodnro”e. “The ,berapeu,ic plasma 
concenhation range of amicdarone has no, been determined m a 
fradirional dor.rerwnse stud”.” In fat,. ii,,Ie msich, can be rained 
for example. be lha, nonresponders tend to have greateramiodarone 
concentrations than responders because nonresponders are move 
likely to receive lvger doses in rhe presence of a “no”res~ons,“e” 
arrbvthmia. 
&eenberg et al. do no, seem to address correctly the quesno” of 
whether therapeutic ranges can be es,ablished in palieds receiving 
amicdarone. In fact. 10 mentmn a few limi,a,ions. presenling 
arrhvthmiaa and underlvine cardiac disorders were different. an 
amiodarone and N-desethylamiodarane in a confrolled. mubicenler 
study employing two fixed dose regimens of amicdarone. 4W and 
LW @day, in pauenls wilb complex ventricular an’by,hmlas. In 
addilion. we found Lha, myocardiaUplamn ratios of amlodarane in 
pafirnls receiving long-lerm ,rea,men, lend ,o increase dunng the 
